HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype.

Abstract
A series of myoepithelial cell lines and xenografts derived from benign human myoepithelial tumors of diverse sources (salivary gland, breast, and lung) exhibit common mRNA expression profiles indicative of a tumor-suppressor phenotype. Previously established myoepithelial cell lines and xenografts (HMS-#; HMS-#X) were compared to nonmyoepithelial breast carcinoma cells (MDA-MB-231 and MDA-MB-468, and inflammatory breast carcinoma samples, IBCr, and IBCw), a normal mammary epithelial cell line (HMEC) and individual cases of human breast cancer (zcBT#T), and matched normal human breast tissues (zcBT#N) (overall samples = 22). The global gene expression profile (22,000 genes) of these individual samples was examined using Affymetrix Microarray Gene Chips and subsequently analyzed with both Affymetrix and DChip algorithms. The myoepithelial cell lines/xenografts were distinct and very different from the nonmyoepithelial breast carcinoma cells and the normal breast and breast tumor biopsies. Two hundred and seven specifically selected genes represented a subset of genes that distinguished (P < 0.05) all the myoepithelial cell lines/xenografts from all the other samples and which themselves exhibited hierarchical clustering. Further analysis of these genes revealed increased expression in genes belonging to the classes of extracellular matrix proteins, angiogenic inhibitors, and proteinase inhibitors and decreased expression belonging to the classes of angiogenic factors and proteinases. Developmental genes were also differentially expressed (either over or underexpressed). These studies confirm our previous impression that human myoepithelial cells express a distinct tumor-suppressor phenotype.
AuthorsSanford H Barsky
JournalExperimental and molecular pathology (Exp Mol Pathol) Vol. 74 Issue 2 Pg. 113-22 (Apr 2003) ISSN: 0014-4800 [Print] Netherlands
PMID12710942 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Genetic Markers
  • Protease Inhibitors
  • RNA, Messenger
Topics
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Carcinoma (pathology)
  • Cluster Analysis
  • Epithelial Cells (metabolism, pathology)
  • Extracellular Matrix (metabolism)
  • Gene Expression Profiling (methods)
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Genetic Markers
  • Humans
  • Karyotyping
  • Myoepithelioma (genetics, pathology, ultrastructure)
  • Neovascularization, Pathologic (metabolism)
  • Oligonucleotide Array Sequence Analysis
  • Phenotype
  • Protease Inhibitors (metabolism)
  • RNA, Messenger (genetics, metabolism)
  • Transplantation, Heterologous
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: